Company profile
GENinCode Predictive Genetics
Clinical Genetics and Precision Medicine. Safeguarding your future health.
- Industry
- Biotechnology Research
- Employees
- 45
- Headquarters
- Oxford, England
- Founded
- 2018
- LinkedIn followers
- 6,631
- Office locations
- 3
GENinCode Predictive Genetics company summary
GENinCode Predictive Genetics is a company in the Biotechnology Research industry, headquartered in Oxford, England, founded in 2018. On LinkedIn the company has around 45 employees and 6,631 followers. The company lists 3 office locations. Its listed specialties include Genetic testing, Precision Medicine, Familial Hypercholesterolemia, Thrombophilia, Repeated Pregnancy Loss.
What technology does GENinCode Predictive Genetics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About GENinCode Predictive Genetics
GENinCode specializes in risk assessment and prediction of cardiovascular disease , thrombosis and familial hypercholesterolemia . Cardiovascular disease (CVD) is a broad disease classification including coronary artery disease such as angina and myocardial infarction often referred to as heart attack. CVD also includes stroke, heart failure, hypertension and other vascular heart diseases and is the leading cause of death and disability worldwide accounting for 1 in every 4 deaths in the United States. GENinCode provides advanced genomic technology, products and recommendations fully validated by our scientific and clinical team. Our goal is to provide doctors and health care practitioners with advanced health information that combines both traditional clinical measures with a patient’s genetic information to provide a comprehensive risk assessment and clinical recommendation to help decision-making. Our technology helps select the optimal treatment pathway and informs and educates patients to become more aware of their cardiovascular risk helping patient adherence and empowerment to better manage their health. GENinCode technology and advanced genomic products provide information that helps patients and healthcare practitioners to assess and predict the onset of cardiovascular disease, thrombosis, and the diagnosis of Familial Hypercholesterolemia. Our online reporting system SITAB® helps inform doctors of their patients’ health risk enabling patient behavioral and lifestyle changes alongside delivering the most effective therapies and treatment pathways.
Specialties
Where is GENinCode Predictive Genetics located?
GENinCode Predictive Genetics lists 3 office locations.
Compare companies similar to GENinCode Predictive Genetics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
GENinCode Predictive Genetics genincode.com | Biotechnology Research | 45 | 2018 | Oxford, England |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about GENinCode Predictive Genetics
What does GENinCode Predictive Genetics do?
GENinCode specializes in risk assessment and prediction of cardiovascular disease , thrombosis and familial hypercholesterolemia . Cardiovascular disease (CVD) is a broad disease classification including coronary artery disease such as angina and myocardial infarction often referred to as heart attack. CVD also includes stroke, heart failure, hypertension and other vascular heart diseases and is the leading cause of death and disability worldwide accounting for 1 in every 4 deaths in the United States. GENinCode provides advanced genomic technology, products and recommendations fully validated by our scientific and clinical team. Our goal is to provide doctors and health care practitioners with advanced health information that combines both traditional clinical measures with a patient’s genetic information to provide a comprehensive risk assessment and clinical recommendation to help decision-making. Our technology helps select the optimal treatment pathway and informs and educates patients to become more aware of their cardiovascular risk helping patient adherence and empowerment to better manage their health. GENinCode technology and advanced genomic products provide information that helps patients and healthcare practitioners to assess and predict the onset of cardiovascular disease, thrombosis, and the diagnosis of Familial Hypercholesterolemia. Our online reporting system SITAB® helps inform doctors of their patients’ health risk enabling patient behavioral and lifestyle changes alongside delivering the most effective therapies and treatment pathways.
How many employees does GENinCode Predictive Genetics have?
GENinCode Predictive Genetics has around 45 employees on LinkedIn.
Where is GENinCode Predictive Genetics headquartered?
GENinCode Predictive Genetics is headquartered in Oxford, England.
Where does GENinCode Predictive Genetics have offices?
GENinCode Predictive Genetics lists 3 office locations, including Oxford, England OX4 4GP, GB; Barcelona, ES, ES; Oxford, OX4 4GP, GB.
When was GENinCode Predictive Genetics founded?
GENinCode Predictive Genetics was founded in 2018.
Build a lead list from companies like GENinCode Predictive Genetics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.